Intro to HIV Flashcards

1
Q

outline the NICE HIV testing guidance

A
  1. in areas of high prevalence, offer and recommend HIV testing on admission to hospital to everyone who hasn’t been previously diagnosed with HIV and who is undergoing blood tests for another reason
  2. in general practice offer and recommend HIV testing to everyone wo has not previously been diagnosed with HIV and who: registers with the practice or is undergoing blood tests for another reason and has not had a HIV test in the previous year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the recommendations for the public

A
  1. everyone should know their hIV status
  2. all men who have ever had sex with another man should have a HIV test
  3. Gay, bisexual and other MSM should have a HIV test at least annually, or 3 monthly if having UPSI with new or casual partners
  4. people born in countries where HIV is common, should have an HIV test and repeat annually if UPSI with new or casual partners
  5. anyone who is diagnosed with HIV should accept the clinical recommendation that they start treatment immediately
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give examples of places where prevalence >1%

A

africa, south America, Asia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does stigma lead to

A

discourages people from testing and accessing care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the different types of antiretroviral drugs

A
  1. fixed dose combinations
  2. nucleoside or nucleotide reverse transcriptase inhibitors
  3. non nucleotide reverse transcriptase inhibitors
  4. integrase inhibitors
  5. CCR5 inhibitors- entry inhibitor
  6. b/PI- boosted protease inhibitor
  7. pharmacokinetic boosters
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

give examples of fixed dose combination antiretroviral drugs

A
  • atripla
  • biktarvy
  • eviplera
  • odefsey
  • trimmeq
  • genvoya
  • stribild
  • symtuza
  • delstrigo
  • Novato
  • juluca
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

give examples of NRTI antiretrovirals

A
  • tenofovir DF + emtricitabine (truvada)
  • TAF + emtricitabine (descovy)
  • abacavir + lamivudine (kivexa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

give examples of NNRTI antiretrovirals

A
  • efavirenz
  • nevirapine
  • etravirine
  • rilpirivine
  • doravirine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

give examples of INI retrovirals

A
  • raltegravir
  • dolutegravir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

give examples of CCR5 inhibitors

A
  • maraviroc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

give examples of b/PI boosted protease inhibitors

A
  • atazanavir
  • darunavir
  • darunavir/cobicistat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

give examples of pharmacokinetic booster antiretrovirals

A
  • cobicistat
  • ritonavir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the main points of action of ART classes

A
  1. entry inhibitors- fusion inhibitors and CCR5 inhibitors
  2. Reverse transcriptase inhibitors- nucleoside analogues and non nucleoside analogues
  3. protease inhibitors
  4. integrase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the function of CCR5

A
  • co receptor
  • for HIV to infect host CD4 cell, has to attach to CCR5, then bind CD4 receptor and fuse to the cell membrane and inject 2 RNA copies into host cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the function of HIV reverse transcriptase

A

facilitates copying 2 viral sRNA strands into dsDNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the function of integrase inhibitors

A

integrate viral dsDNA into host DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the function of protease inhibitors

A

viral protease chop up long proteins, making newly assembled viral particle ready for action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what other research can be used apart from ARV to control HIV

A
  1. vaccines
  2. microbicides
  3. eradicating latency in dormant cells
  4. HIV immunotherapy- cell miutations leading to HIV resistance/eradication
  5. gene therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

give examples of combination prevention of HIV

A
  1. use condoms wherever possible
  2. post exposure prophylaxis- prevents acquisition following potential exposure
  3. treatment as prevention- prevents transmission
    - immediate ART now standard HIV care
  4. pre exposure prophylaxis- prevents acquisition before exposure
  5. expand HIV testing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

give examples of intervention HIV prevention strategies

A

behavioural strategies:
- education and public health campaigns
- condom skills education
- motivational interviewing
circumcision- reduces male to female sexual transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is HIV

A

human immunodeficiency virus
- attacks immune system, specifically CD4 T cells
- virus replicates inside these cells
- overtime it kills CD4 cells, leading to weaker immune system and reduces ability to recognise infection
- if uncontrolled HIV, body can’t fight serious opportunistic infections (TB, pneumonia) which can be fatal
- no cure, but ARVs stops virus from replicating and damaging immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the aim of effective treatment of HIV

A

suppresses virus to low levels so can’t harm patient and can’t pass it on
- low viral load leads to better natural defences and body better equipped to fight infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

when is ART started

A

immediately after positive HIV test
- increases lifespan
- reduces risk of transmission to others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is AIDS

A
  • set of symptoms and illnesses due to immune damage by HIV
  • also called late stage HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

how can HIV be passed on

A
  1. can’t be passed on by touching, kissing, sharing cutlery
  2. transmitted by unprotected sex if patient is not on effective ART (most common)
  3. second most common by sharing needles
  4. low chance of getting HIV from oral sex but advised to use condoms/dental days to prevent STIs
    - higher risk if you have open sores, bleeding gums
  5. HIV absent in sweat- not passed by skin to skin contact
  6. passed through blood, breastmilk, seminal, pre seminal and anal fluids
  7. insect bites can’t transmit HIV
  8. if ARTs started during pregnancy, baby risk of contracting HIV is less than 1%, but without treatment risk is 25%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is a dental dam

A

thin sheet of plastic, provides protection during oral sex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

give examples of ways to prevent HIV

A
  1. getting regularly tested if sexually active
  2. taking PrEP or PEP
  3. Using condoms
  4. never sharing needles
  5. taking medication as prescribed if living with HIV
28
Q

who is PrEP given to

A

people who are HIV negative to reduce the chance of getting HIV
- used where not able to practice safer sex

29
Q

what is PrEP and how is it taken

A
  • short course ART
  • stops exposure to HIV becoming lifelong infection
  • prevents acquisition before exposure where potentially at risk of acquiring hiv
  • isn’t always available and shouldn’t be used as regular form of protection
30
Q

why is it important for patients to adhere to HIV treatment

A
  1. patients should take at same time every day
  2. adherence reduces levels of HIV and reduces resistance to antiretrovirals
  3. regularly missed doses means HIV acquires resistance to ART
31
Q

when is hIV considered undetectable

A
  1. when treatment effectively reduces viral load so low that it can’t be detected in tests
    - <40 copies/ml= undetectable
  2. as long as HIV is undetectable, can’t be transmitted to others
  3. key to have viral load monitored
32
Q

why is it important to diagnose early

A

want to diagnose when CD4 count is higher, to reduce risk of death or AIDs diagnoses in first year after diagnosis

33
Q

describe the Properties of HIV

A
  1. retrovirus- back to front
    - stores genetic info using RNA instead of DNA
    - need to make DNA when enters host to replicate
  2. causes disease slowly
  3. can’t replicate on its own- infects CD4 cells of immune system and uses host machinery in these cells to replicate
  4. overtime HIV kills CD4 cells, reducing ability to recognise and fight infection
  5. if not controlled by treatment, loss of cd4 cells leads to opportunistic infections
    - experiencing a collection of these infections is most advanced stage of HIV (AIDS)
34
Q

describe the structure of HIV

A
  1. spherical virus
  2. outer shell- envelope covered in spikes of glycoproteins gp120 and gp41
    - glycoproteins allow HIV to interact with CD4 receptor on T cells
  3. inside virus= matrix
  4. core of virus is nucleus enclosed in capsid containing reverse transcriptase and integrase
  5. contains 2 strands of RNA- holds genetic material of hIV
  6. HIV RNA composed of 9 genes- contains instructions to make new viruses
35
Q

outline the first step in the HIV lifecycle

A

attachment and entry (binding):
1. process of HIV gaining entry into a cell through 2 steps: attachment, then fusion
2. hiv infects immune cells with a surface CD4 receptor
3. gp120 spikes on surface of HIV cell locks onto cd4 receptor and another co receptor (CCR5)
4. gp41 protein fuses HIV envelope with host cell wall
5. fusion allows HIV capsid to enter host cd4 cell

36
Q

give examples of cd4 receptor cells

A

T lymphocytes, monocytes, macrophages, dendritic cells

37
Q

what are cd4 receptors used for

A

used to signal to other immune components and highlight presence of antigens

38
Q

give examples of ARDs that may block stages of attachment and entry

A
  • CCR5 inhibitors
  • attachment inhibitors
  • fusi9on inhibitors
39
Q

what can be used as a target for vaccines in hiv

A

gp41 and gp120 proteins on surface of virus

40
Q

outline the second step of the HIV lifecycle

A

reverse transcription:
1. hiv RNA must be reverse transcribed in the host cell into proviral DNA
2. once proviral dna is created, it is integrated into DNA of host
3. hiv uses viral reverse transcriptase to connect RNA to proviral dna

41
Q

what types of ARD stop the action of viral reverse transcriptase enzymes

A
  • NRTIs
  • NtRTIs
  • block HIV replication by inserting a nucleoside/nucleotide into chain of hiv dna which terminates chain
  • NNRTIs- block HIV production by directly binding to reverse transcriptase enzyme
42
Q

what is the 3rd step of the HIV lifecycle

A

Integration:
1. after HIV RNA is converted to DNA, hiv integrase enzymes attach to end of proviral dna strand and enters host cell nucleus
2. proviral dna then binds to host dna and integrates into host dna
3. hiv integrase inhibitor drugs block transfer of hiv RNA into host dna
4. after proviral dna integrated into host dna, hiv remains dormant in cell
- cell is latently infected
- difficult to detect latently infected cells, even with high sensitivity tests

43
Q

what is the 4th step of the HIV lifecycle

A

transcription and translation:
1. cell produces hiv RNA if it recieves a signal to become active
2. cd4 cells activated when encounter an infective agent (antigen)
3. when cd4 cell is activated, hiv uses host RNA polymerase enzymes to make mRNA
4. mRNA provides instructions to make long viral polyproteins (inactive)
5. long chains of hiv proteins cut into smaller chains by hiv proteases which activates them

44
Q

what is the final step of the HIV lifecycle

A

assembly and budding:
1. protein chains assemble into new viruses at host cell wall
2. hiv protease inhibitors block activity of hiv protease enzymes
3. as virus buds from cell wall, genome is enclosed in a capsid (produced by hiv gag protein)
4. after new virus is assembled, this leaves out by pushing through cell wall
5. to leave host cell completely and become infectious, virus must take lipids from cell wall and make surface glycoproteins
6. maturation inhibitor drugs being developed to block cutting of gag protein needed to produce mature virus

45
Q

what is the first clinical stage of infection

A
  1. primary (acute) HIV infection- hiv enters body by infecting cd4 cells of mucous membrane of vagina or rectum, or by direct infection of cd4 T cells in bloodstream
    - at this stage, PrEP can prevent hiv infection if taken consistently
46
Q

when can post exposure prophylaxis be used

A

used with a 3 drug ARD combination
- can prevent hiv up to 72 hours post exposure

47
Q

describe the role of dendritic cells in hiv

A
  • first cells to encounter hiv
  • transport infectious agents to lymph nodes
  • when hiv arrives in lymph nodes (24-48 hours post exposure), it activates other immune cells like cd4 T cells
  • hiv replicates in lymph nodes
48
Q

how is hiv detected in lymph nodes

A
  • not detectable in blood by viral blood testing or antibody testing
  • only detectable by taking a biopsy of lymph node tissue
  • 3 drug ARD initiated in this stage of hiv infection to restrict spread of hiv to cells of immune system which can form a reservoir of hiv
49
Q

when is hiv not detectable in blood

A

7-21 days
- several weeks after infection, hiv is detectable in blood by viral load testing
- this is when people may experience symptoms such as fever, body rash, swollen glands

50
Q

what is the most common symptom of acute hiv infection

A

fever and rash
- may last up to 2 weeks
- viral load reaches its peak at this time and cd4 cell levels fall

51
Q

when is hiv antigen (p24) detectable

A

around 3-4 weeks after infection
- using 4th generation antibody/antigen tests which combine detection of hiv antibodies and hiv antigens and show a positive result
- further 4-8 days- hiv antibody only tests using blood show a positive result
- hiv levels begin to fall and cd4 levels begin to rise

52
Q

what occurs after 6 months

A

viral load and cd4 levels stabilise at a level known as set point

52
Q

what occurs in chronic HIV infection

A
  • hiv gradually reduces number of cd4 cells until cd4 count falls below 200 cells/mm3
  • below this, risk of developing AIDS related infections increases
52
Q

what is the asymptomatic phase

A

period where hiv doesn’t cause illness
- lasts 10 years on average
- length depends on how quickly cd4 cell count declines
- if very high viral load (>100,000 copies/ml), cd4 cells are lost quicker

53
Q

what is the role of ART

A
  1. suppresses hiv to undetectable levels, restores cd4 count to normal levels and prevents disease if started at any time during asymptomatic phase
    - taken daily
    - guidelines recommend start taking treatment soon after diagnosis
54
Q

what monitors progression of hiv disease during asymptomatic phase

A

cd4 cell counts and viral load tests

55
Q

where are reservoirs of latently infected cells established

A

in lymph nodes, spleen and gut
- latently infected cells can proliferate without activation but are not recognised as pathogenic

56
Q

what is iBASE

A

community led charity, supporting people living with hiv by providing treatment information
- work closely with hiv specialists

57
Q

what are needle exchange schemes used for

A

reduces blood borne virus transmission
- doesn’t encourage drug use but safer drug use for people who are going to use drugs anyway
- hiv more easily transmitted in presence of other STIs

58
Q

describe the use of treatment as prevention

A
  1. prevents transmission u=u
    - undetectable= untransmissable
  2. immediate ART now standard hIV care
  3. if someone is hiv positive and has partner who is hiv negative
59
Q

describe the use of post exposure prophylaxis

A
  1. used for sexual and occupational exposure (needlestick injury)
  2. within 72 hours of exposure but ideally sooner
  3. one month course of 3 ARTs- high success rate of preventing conversion
  4. prevents acquisition following potential exposure
60
Q

what are the benefits of hiv testing

A
  1. improves quality of life of people with hiv by enabling early treatment
  2. reduces transmission
  3. can have asymptomatic hiv- testing is only way to know status
  4. knowing status allows people to get treatment and not pass virus on
  5. people aged over 16 can order a free hiv test
61
Q

what is the test and treat programme

A
  • aim for 90% of new diagnoses to be taking ARVsby 30 days
    -aim for 98-100% PLWH to be taking effective treatment
  • aim for 100% PLWH have undetectable viral loads
62
Q

describe how HIV testing can be expanded to get towards zero undiagnosed HIV infection

A
  1. annual testing and increase awareness of testing
  2. increase availability of tests for targeted populations
    - self tests
    - pharmacies, primary care
  3. sign post using social media
  4. use anti stigma campaign/PrEP to further boost testing
63
Q
A